Rachel Alvarenga-Brant

Rachel Alvarenga-Brant

Auto-generated profile, based on publicly available information

Rachel Alvarenga-Brant

Department of Clinical Dentistry, Pathology and Oral Surgery, Faculty of Dentistry Universidade Federal de Minas Gerais Belo Horizonte Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2023 in The Journal of the American Dental Association
Verified
Journal Article
Closed access
LPLuciana Póvoa-Santos
Luciana Póvoa-Santos
Rogério Lacerda-SantosRogério Lacerda-Santos
Rogério Lacerda-Santos
RARachel Alvarenga-Brant
Rachel Alvarenga-Brant
SNSarah Queiroz Notaro
Sarah Queiroz Notaro
ASAna Clara Souza-Oliveira
Ana Clara Souza-Oliveira
CMCarolina Martins
Carolina Martins

28 August 2023 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
GMGustavo Henrique Mattos‐Pereira
Gustavo Henrique Mattos‐Pereira
RERafael Paschoal Esteves‐Lima
Rafael Paschoal Esteves‐Lima
LCLuís Otávio Miranda Cota
Luís Otávio Miranda Cota
RARachel Alvarenga‐Brant
Rachel Alvarenga‐Brant
FCFernando Oliveira Costa
Fernando Oliveira Costa

13 July 2024 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
RARachel Alvarenga-Brant
Rachel Alvarenga-Brant
SNSarah Queiroz Notaro
Sarah Queiroz Notaro
CSCRISTINE MIRON STEFANI
CRISTINE MIRON STEFANI
GCGraziela De Luca Canto
Graziela De Luca Canto
APAlexandre Godinho Pereira
Alexandre Godinho Pereira
CMCarolina Martins
Carolina Martins
Background: To assess the reporting of the certainty of the evidence using the GRADE approach in systematic reviews of interventions in pediatric dentistry. Methods: The inclusion criteria were systematic reviews of randomized clinical trials (RCTs) and non-randomized studies of interventions (NRSIs) in pediatric dentistry that reported the certainty of the evidence through the GRADE approach. Paired independent reviewers screened the studies, extracted data, and appraised the methodological quality using the Assessing the Methodological Quality of Systematic Reviews (AMSTAR 2) tool. The certainty of the evidence was extracted for each outcome. A descriptive analysis was conducted. Results: Around 28% of pediatric dentistry reviews of interventions used the GRADE approach (n = 24). Twenty reviews reported 112 evidence outcomes from RCTs and 13 from NRSIs using GRADE evidence profile tables. The methodological quality was high (16.7%), moderate (12.5%), low (37.5%), and critically low (33.3%), fulfilling the majority of the AMSTAR 2 criteria. The certainty of the evidence for outcomes generated from RCTs and NRSIs was very low (40.2% and 84.6%), low (33.1% and 7.7%), moderate (17.8% and 7.7%), and high (9.8% and 0.0%). The main reasons to downgrade the certainty were due to (for RCTs and NRSIs, respectively): risk of bias (68.8% and 84.6%), imprecision (67.8% and 100.0%), inconsistency (18.8% and 23.1%), indirectness (17.8% and 0.0%), and publication bias (7.1% and 0.0%). Conclusion: The proportion of systematic reviews assessing the certainty of the evidence using the GRADE approach was considered small, considering the total initial number of published pediatric dentistry reviews of intervention. The certainty of the evidence was mainly very low and low, and the main problems for downgrading the certainty of evidence were due to risk of bias and imprecision. Registration: PROSPERO database #CRD42022365443.

16 April 2024 in International Journal of Paediatric Dentistry
Verified
Journal Article
Closed access
ASAna Clara Souza‐Oliveira
Ana Clara Souza‐Oliveira
MPMarco Aurelio Benini Paschoal
Marco Aurelio Benini Paschoal
TSThiago dos Santos
Thiago dos Santos
RARachel Alvarenga‐Brant
Rachel Alvarenga‐Brant
MAMauro Henrique Abreu
Mauro Henrique Abreu
CMCarolina Martins
Carolina Martins

8 August 2025 in Midwifery
Verified
Journal Article
Closed access
LGLaura Gismonti-Gaudêncio
Laura Gismonti-Gaudêncio
LPLuciana Póvoa-Santos
Luciana Póvoa-Santos
RARachel Alvarenga-Brant
Rachel Alvarenga-Brant
GCGraziela De Luca Canto
Graziela De Luca Canto
LALucas Guimarães Abreu
Lucas Guimarães Abreu
CMCarolina Martins
Carolina Martins

8 September 2025 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Open access
MSMarina Rocha Fonseca Souza
Marina Rocha Fonseca Souza
MGMoisés Willian Aparecido Gonçalves
Moisés Willian Aparecido Gonçalves
RMRoberta Rayra Martins‐Chaves
Roberta Rayra Martins‐Chaves
RARachel Alvarenga‐Brant
Rachel Alvarenga‐Brant
Bruno Ramos ChrcanovicBruno Ramos Chrcanovic
Bruno Ramos Chrcanovic
CMCarolina Martins
Carolina Martins
Background: Oral and plunging ranulas require effective treatment strategies to minimize recurrence; yet no consensus exists on the most effective approach. Objectives: This systematic review evaluated several treatments for the recurrence of oral and plunging ranulas. Methodology: A comprehensive search was conducted in five bibliographic databases and gray literature. Randomized and non‐randomized studies were included if they investigated treatment approaches for oral or plunging ranulas. Two independent reviewers screened studies, extracted data, and assessed the risk of bias. The primary outcome was recurrence of (1) oral and (2) plunging ranula. For each type of ranula, a random‐model frequentist network meta‐analysis (NMA) was established for seven treatment strategies: enucleation, micromarsupialization, marsupialization, marsupialization with packing, partial sublingual gland excision, sublingual gland excision, and sublingual gland excision plus submandibular gland excision. A minimal important difference (MID) and the GRADE approach for NMA were used for interpretation of data. Results: Eighteen studies were included (all non‐randomized—14 for oral ranula and six for plunging ranula). No treatment demonstrated clear superiority in preventing recurrence. Certainty of evidence was low to very low for oral ranulas and very low for plunging ranulas, primarily due to the risk of bias, imprecision, and intransitivity. Conclusions: Given the low certainty of evidence, no single treatment can be considered superior to others. Future research should prioritize longer follow‐up randomized controlled trials.